# Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration

> **NCT01209611** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Tissue Expansion;
- Skin Regeneration;
- Reconstruction;
- Bone Marrow Mononuclear Cells

## Interventions

- **PROCEDURE:** Autologous bone marrow mononuclear cells
- **PROCEDURE:** Placebo

## Key facts

- **NCT ID:** NCT01209611
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2013-10
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209611, "Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01209611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*